This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1992-1997.
Company Filing History:
Years Active: 1992-1997
Title: Joachim Lanz: Innovator in Pharmaceutical Chemistry
Introduction
Joachim Lanz is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds with therapeutic potential. With a total of 2 patents, his work has implications for the treatment of various medical conditions.
Latest Patents
Lanz's latest patents include the invention of 3-amino-tetrahydrocarbazole-propanoic acid esters. This invention relates to new intermediates that can be utilized in the preparation of thromboxane-antagonistic active compounds. Additionally, he has developed a process for the preparation of (7-APCA), which is an important synthesis intermediate in the production of cephalosporin-like antibiotics. This process involves treating specific compounds with strong protonic or Lewis acids, showcasing his expertise in complex chemical synthesis.
Career Highlights
Joachim Lanz is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to work on innovative projects that push the boundaries of pharmaceutical research. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Lanz has collaborated with esteemed colleagues such as Paul Naab and Ulrich Rosentreter. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Joachim Lanz is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His patents and collaborations reflect his commitment to innovation in the field.